Friday, 20 December 2019

Recombinant DNA Technology Market - Size, Trends, Demand and Growth

Market Scenario
The recombinant DNA technology is a process that manipulates and alters the DNA sequences, resulting in a genetically modified organism and product. These genetically modified products or organisms have superior or specific ability such as resistance to certain chemicals, high productivity, and survival abilities in harsh conditions (GM crops).

Regional Analysis
The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region holds the largest market share of the global recombinant DNA technology market due to the presence of effective regulations pertaining to the approval of recombinant therapeutics and other Genetically Modified (GM) products. F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, Monsanto Company, Eli Lilly and Company, and Biogen Inc. are some of the major companies operating in this space that are responsible for the growth of the Americas recombinant DNA technology market.
Furthermore, there is an increasing need to improve the recombinant proteins production capacity by several folds in Europe. The increase in demand for effective therapeutics for the treatment of diseases and technological advancements in this sector are anticipated to drive the growth of the European recombinant DNA technology market.
Asia Pacific is expected to emerge as the fastest growing regional market for the global recombinant DNA technology market. The increasing awareness about the growing genetic diseases and disorders, developing healthcare infrastructure, increasing spending on healthcare, increasing government initiatives to improve public health, and advances in medical fields are driving the market growth.
The Middle East and Africa is expected to experience a limited growth due to less demand for genetic testing. The Middle East is growing significantly as compared to the African recombinant DNA technology market owing to the increase in aging population, innovations in genetic testing, and increase in the number of chronic disease cases. 


Segmentation
The global recombinant DNA technology market is segmented on the basis of product, component, application, and end-user.
On the basis of product, the global recombinant DNA technology market is segmented into medical, non-medical, and others. The medical segment is divided into therapeutic agent, human protein, and vaccines. The non-medical segment is divided into biotech crops, specialty chemicals, and others.
On the basis of component, the global recombinant DNA technology market is segmented into expression system, cloning vector, and others. The expression system segment is divided into mammalian, bacteria, yeast, baculovirus/insect, and others. The cloning vector segment is divided into plasmid, phage, cosmid, Bacterial Artificial Chromosome (BAC), Yeast Artificial Chromosome (YAC), and Human Artificial Chromosome (HAC).
On the basis of application, the global recombinant DNA technology market is segmented into food and agriculture, health and disease, environment, and others.
On the basis of end-user, the global recombinant DNA technology market is segmented into biotechnology companies, academic and government research institutes, pharmaceuticals, and others.
Key Players
Some of the key players in the global recombinant DNA technology market are F. Hoffmann-La Roche Ltd (Switzerland), Profacgen (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland), Genscript Biotech (U.S.), Pfizer Inc. (U.S.), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Merck & Co., Inc. (U.S.), Biogen Inc. (U.S.), Biocon Limited (India), GlaxoSmithKline plc (UK), New England Biolabs (U.S.), Cibus (U.S.), Monsanto Company (U.S.), Horizon Discovery Group PLC (U.S.), Boehringer Ingelheim (Germany), and others.

Trending Report 



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Big Data Pharmaceutical Advertising Market Analysis Report 2020- Global Industry Trends by Forecast to 2023

Market Insights:
Market Research Report (MRFR)’s report has revealed that the global big data pharmaceutical advertising market is set to witness exponential growth and reach a valuation of USD 4477.3 Mn by the end of the forecast period. The growth is attributable to the strong value maintained by the pharmaceutical industry.
The intensified competitive landscape and the adoption of big data in the pharmaceutical industry for gaining an edge over competitors have accelerated revenue creation for the big data pharmaceutical advertising market players. The growing budgets for investments in advertising by the pharmaceutical companies are set to have a positive influence on the market proliferation. Furthermore, the increasing trend of digitalization has opened growth avenues for the market players.
Big data enhance the pathway to reach the targeted customers and optimizes costs associated with advertising. This has catalyzed its adoption in the pharmaceutical industry and is likely to augur well for the big data pharmaceutical advertising market expansion over the projection period. The market for big data pharmaceutical advertising resonates strong growth opportunities presently and is estimated to exhibit a steep rise in the market proliferation across the review period.

Market Segmentation:
By channel, the global big data pharmaceutical advertising market has been segmented into product website & e-commerce, social media, search engine, and mobile ads.
By application, the big data pharmaceutical advertising market is segmented into product & service targeting, customer targeting, and branding.


Regional Analysis:
By region, the global big data pharmaceutical advertising market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America held the largest share of the market in 2015 which accounted for 42.3% share. It is likely to retain its prominence over the next couple of years and is estimated to reach a valuation of USD 1833.5 Mn by 2023. The growth is attributable to the developed healthcare sector, the presence of key players, intensified competition in the market, etc.
Europe is the second largest market for big data pharmaceutical advertising market currently. It is estimated to show positive growth throughout the forecast period. Meanwhile, Asia Pacific is projected to register a CAGR of 13% during the assessment period 2017 to 2023. The consolidation of fast-developing economies such as China and India are expected to boost the adoption of big data advertising in the pharmaceutical industry. However, the Middle East & Africa Big Data Pharmaceutical Advertising market is growing is expected to exhibit sluggish growth due to poor socio-economic conditions in the African countries.
Competitive Dashboard:
Some of the key players profiled in the report are International Business Machines Corporation (U.S.), Oracle (U.S.), Statistical Analysis System (U.S.), Tata Consultancy Services Limited (India), and TAKE Solutions Ltd (U.S.) among others.
Industry Developments:
In April 2018, Precisioneffect, the healthcare advertising agency has acquired Big Pink a leading European multichannel healthcare marketing agency.
In July 2018, Huntsworth Plc., the parent company of the Evoke Group of health and wellness marketing companies, acquired Giant Creative Strategy, focused on health care multi-channel marketing, backed by robust data and analytics offering.

Latest Trending Reports




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Medical Oxygen Concentrators Market in-depth approaches behind the Success Of Top Players like- Philips Healthcare, Invacare Corporation, AirSep Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed

Medical Oxygen Concentrators Market Highlights
The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home.
Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea. Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.
Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.
Medical Oxygen Concentrators Market Segmentation
The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has been divided into the continuous flow and pulse dose.
Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.
By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.
Medical Oxygen Concentrators Market Key Players
Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.
Regional Analysis
The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.
Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.
The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.
The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Trending Reports


About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

What’s Driving the Patient Registry Software Market | Top Players in the Current Competition are: ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc.

The Global Patient Registry Software Market is expected to register a CAGR of 11.08% during the forecast period with a market value of USD 1,998.83 Million till 2025.
Patient registry software is an organized system that utilizes observational study methods for collecting clinical as well as non-clinical patient data for evaluation of specified outcomes for a population that is defined by a particular disease, condition, or exposure, and that serves a predetermined clinical, scientific, or policy purposes.
The high adoption rate of electronic health records and increasing use of patient registry data for post-marketing surveillance is anticipated to drive the market growth of the global patient registry software market. However, privacy and data security-related concerns are expected to restrict the market growth.
Global Patient Registry Software Market: Segmental Analysis
The global patient registry software market has been segmented on the basis of deployment model, software, type of registry, and end user.
By mode of software, the global patient registry software market has been segmented into standalone and integrated. Among these, the integrated software is estimated to project the largest market share.
By mode of deployment model, the global patient registry software market has been segmented into on-premise model and cloud-based model. Among these, the cloud-based model is expected to occupy the largest market share owing to its increased adoption throughout the assessment period.
By mode of type, the global patient registry software market has been segmented into disease registries and product registries.
By mode of end-users, the global patient registry software market has been segmented into hospitals & medical centers, pharmaceutical & medical device companies, government & non-government agencies, and others. Among these, the pharmaceutical & medical device companies’ segment is estimated to occupy the largest share in the market.
Regional Insights
Geographically, the patient registry software market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.
Considering the global scenario, the American region is considered to dominate the global patient registry software market. The growth is credited to the increased use of patient registry data for post-marketing surveillance, the presence of well-established players, and surging adoption EHRs in this region. Moreover, the increased number of registered hospitals coupled with the growing number of patient visits for physical checkups are some of the major factors likely to drive the market in this region.
The Asia Pacific region is predicted to create new opportunities for the market. Several initiatives undertaken by the government in order to enhance population health management is driving the market growth in this region. Moreover, the rising pressure of the government on the healthcare organizations in order to minimize the cost of healthcare and improve the quality of care is estimated to foster the market growth in this region.
Industry Updates
On January 2018, a leading innovator in EDC technology named Dacima Software, Inc. announced that they have signed a contract with the Derby Teaching Hospital and have been awarded an RFP in the U.K. for the use of Dacima’s Electronic Data Capture software.
Competitive Dashboard
The prominent players operating in the patient registry software market are Liaison Technologies. (US), Phytel Inc. (US), IFA systems AG (Germany), QUINTILES IMS HOLDINGS INC. (US), FIGmd Inc. (US), McKesson Corporation (US), ImageTrend Inc. (US), Dacima Software Inc. (US), CECity.com Inc. (US), and Global Vision Technologies Inc. (US).
Most Trending Reports
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Thursday, 19 December 2019

Urinalysis Test Market Grow by CAGR of 5.85% From (2019 to 2025)

Market Highlights
Urinalysis Test Market is expected to register a CAGR of 5.85% during the forecast period, with a market value of USD 1568.46 Million till 2025.
Segment Analysis
The Global Urinalysis Test Market is segmented into product type, test type, application, and end-user
On the basis of product type, the urinalysis test market has been classified as consumables and instruments. The consumables segment has been further divided into pregnancy & fertility kits, dipsticks, disposables, and reagents. The instruments segment has been additionally categorized as automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. The automated urine analyzers segment has been further classified as biochemical urine analyzers, sediment urine analyzers, and integrated urine analyzers. The sediment urine analyzers segment has been additionally bifurcated into microscopy analyzers and flow cytometry analyzers. The consumables segment is expected to command the market over the assessment period owing to the repetitive use of consumables during urinalysis procedures.
Regional Analysis
The Global Urinalysis Test Market has been segmented on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The European urinalysis test market has been additionally segmented into Western Europe and Eastern Europe. The Western Europe urinalysis test market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The urinalysis test market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. The urinalysis test market in the Middle East & Africa has been bifurcated into the Middle East and Africa.
The Americas was the largest market for urinalysis tests in 2018 due to the rising demand for automated urine analyzers, technological advancements in urinalysis test instruments, and rising prevalence of kidney and liver diseases in the US and Canada. In North America, the US held the largest share of the market in 2018 owing to the presence of significant players focused on manufacturing urine analyzers and consumables, rising research initiatives in the field of urinalysis, and growing awareness about personalized medicines. On the other hand, Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to rapidly developing medical technology, increasing demand for urine testing products, surging geriatric population, and growing awareness about urinalysis tests in China, India, Japan, and Australia.
Market Players
MRFR recognizes the following companies as the Key Players in the Global Urinalysis Test Market— Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US), URIT Medical Electronic Ltd (China), Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), and Alere Inc. (US).
Key Findings of the Study
  • The Global Urinalysis Test Market was valued at USD 1057.01 Million in 2018, is estimated to grow at USD 1568.5 Million By 2025 at a CAGR of 5.85% during the assessment period.
  • Americas accounted for the largest share of the global market due to the presence of key market players and increasing the rising prevalence of diseases, and government support are driving the growth of the market in this region.
  • On the basis of product type, consumables accounted for the largest market share of 8% in 2018, with a market value of USD 590.15 Million.
Hottest Trending Reports
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

CBD Oil (Cannabidiol Oil) Market Value Chain, Factor Analysis, Region and Forecasts To 2023

CBD oil market is predicted to touch USD 3782.32 million at a 38.45% CAGR between 2015-2023

The CBD Oil Market is estimated to be valued at USD 3782.32 Million by 2024 and expected to grow at a CAGR of 38.45% during the forecast period. CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc.
From the past few years, the market for CBD oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil.
Segment Analysis
Global CBD oil market has been segmented on the basis of type, and application. On the basis of type, the market has been divided into hemp-derived and marijuana-derived types. The Hemp-derived CBD oil type is holding the major share of the overall CBD oil market. It has been estimated that the hemp-derived segment is growing at the highest CAGR to reach USD 2,092.97 Million by the end of 2024. Most of the legal CBD-based products in the market are hemp-based. According to the 2018 Farm Bill, companies can legally grow, manufacture, possess, and sell hemp-derived CBD products.  
Based on application, the global CBD oil market is segmented into pharmaceuticals, food, cosmetics, and others. Among these segments, the cosmetic industry accounts for the largest market share owing to the anti-inflammatory and non-psychoactive properties of CBD. Moreover, CBD infused beauty products are a major trend these days. For instance, Folium Biosciences, the US-based cannabinoid producer, offers cosmeceuticals which include CBD infused moisturizing relief cream.


List Of Tables:
TABLE 1 PRIMARY INTERVIEWS 16
TABLE 2 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 32
TABLE 3 AMERICAS HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33
TABLE 4 NORTH AMERICA HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33
TABLE 5 EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34
TABLE 6 WESTERN EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34
TABLE 7 ASIA-PACIFIC: HEMP BASED PRODUCTS MARKET, BY COUNTRY 2015–2023 (USD MILLION) 35
TABLE 8 REST OF THE WORLD (ROW) HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 35

Read More Here !! https://www.marketwatch.com/press-release/cbd-oil-cannabidiol-oil-market-research-report-2019-industry-trend-growth-future-scope-demand-top-key-players-update-hemp-oil-demand-and-regional-forecast-2019-12-04
Posted by at 7 comments:
Labels: , , ,

Worldwide 3D printed medical Implants Market Size, Share Analysis, Strategies, Revenue and Forecasts to 2024

Market Highlights
The global 3D printed medical implants market held a market value of USD 1,124.68 million in 2018 and is projected to grow at a CAGR of 18.1% over the forecast period.   
3D printing is a procedure that uses a layer by layer method for the creation of a real or physical object from a digital design. This technology is in its early stage in healthcare applications and holds strong potential for a wide variety of applications in medical implants. Factors such as vast technological advancements in the medical device industry and strategic investments done by leading players are expected to drive the market growth. For instance, EnvisionTEC signed a partnership with Abergower as its global reseller partner to expand Envision’s global footprints in 3D printed medical devices market in November 2017. Moreover, the rising need for medical implantation due to the high prevalence of bone-dental disorders are driving the growth of the global 3D printed medical implants market.
On the other hand, the high cost of implants and stringent government regulations are likely to hamper the growth of the market.
Segmentation
The global 3D printed medical implants market has been segmented into component type, implantation technology, application, and end user.
By implantation technology, the market has been segmented into laser beam melting, electronic beam melting, droplet deposition, and others.
Based on application, the market has been segmented into dental, orthopedic, and cranio-maxillofacial.
The market, by end user, has been segmented into hospitals, medical device companies, research and academic institutes, and others.
Key Players
Some of the prominent players in the global 3D printed medical implants market are Materialise (Belgium), Renishaw plc (UK), 3D Systems, Inc. (US), Stratasys Ltd(Israel), ENVISIONTEC, INC. (US), Arcam AB (Sweden), SLM Solutions (Germany), Oxford Performance Materials (US), Bio3D Technologies (Singapore), Cyfuse Biomedical K.K. (Japan), TRUMPF (Germany), ADEISS (US), OsseoMatrix (US), AnatomikModeling (France), EIT Emerging Implant Technologies (Germany).
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Equipment Trends & Assessment
...
Hottest Trending Reports
Global Denture Adhesive Market Research Report - Forecast to 2021
Patient Registry Software Market Research Report - Global Forecast till 2023
Hair Transplant Market Research Report - Global Forecast till 2023
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)